Biobanking of human biological material and the principle of noncommercialisation of the human body and its parts
The prohibition of commercialisation of the human body and its parts is not applied consistently and suffers from many exceptions in the human biological material (HBM) market. Examples include the possibility of patenting certain HBM-derived products and their commercial marketing or payments for b...
| Authors: | ; ; |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Wiley-Blackwell
2023
|
| In: |
Bioethics
Year: 2023, Volume: 37, Issue: 2, Pages: 154-164 |
| RelBib Classification: | NCH Medical ethics TK Recent history XA Law |
| Further subjects: | B
Ethics
B Law B Donation B human biological material B commercialisation |
| Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
MARC
| LEADER | 00000caa a22000002 4500 | ||
|---|---|---|---|
| 001 | 1831758741 | ||
| 003 | DE-627 | ||
| 005 | 20230418161107.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230121s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bioe.13127 |2 doi | |
| 035 | |a (DE-627)1831758741 | ||
| 035 | |a (DE-599)KXP1831758741 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |a Pawlikowska, Joanna |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Biobanking of human biological material and the principle of noncommercialisation of the human body and its parts |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The prohibition of commercialisation of the human body and its parts is not applied consistently and suffers from many exceptions in the human biological material (HBM) market. Examples include the possibility of patenting certain HBM-derived products and their commercial marketing or payments for blood donations. Thus, the current practice of marketing HBM-derived products makes the altruistic donor most vulnerable to exploitation while being deprived of benefits. There seem to be two ways to improve this state of affairs. The first is to apply consistently the prohibition of commercialisation of the body and its parts to commercially marketed tissue and cell products as well. This would require limiting the possibility of financial gain associated with the processing, distribution and sale of HBM-based products. Such a solution, however, does not seem to gain wide acceptance or have a chance of implementation in the near future. Therefore, introducing more transparent rules and greater donor empowerment seems more reasonable by exempting HBM from the ban on commercialisation under certain conditions and with clear limitations. | ||
| 601 | |a Biobank | ||
| 650 | 4 | |a Law | |
| 650 | 4 | |a human biological material | |
| 650 | 4 | |a Ethics | |
| 650 | 4 | |a Donation | |
| 650 | 4 | |a commercialisation | |
| 652 | |a NCH:TK:XA | ||
| 700 | 1 | |a Pawlikowski, Jakub |e VerfasserIn |4 aut | |
| 700 | 1 | |a Krekora-Zając, Dorota |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bioethics |d Oxford [u.a.] : Wiley-Blackwell, 1987 |g 37(2023), 2, Seite 154-164 |h Online-Ressource |w (DE-627)271596708 |w (DE-600)1480658-7 |w (DE-576)078707986 |x 1467-8519 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2023 |g number:2 |g pages:154-164 |
| 856 | 4 | 0 | |u https://doi.org/10.1111/bioe.13127 |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.13127 |x Verlag |z lizenzpflichtig |3 Volltext |
| 935 | |a mteo | ||
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 4250369021 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1831758741 | ||
| LOK | |0 005 20230421111107 | ||
| LOK | |0 008 230121||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-Tue135)IxTheo#2023-01-20#6F87C5317D66EF7B5A4CEEAB2724D1721B1D9A62 | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a ixzs |a zota | ||
| LOK | |0 936ln |0 1550736558 |a NCH | ||
| LOK | |0 936ln |0 1442053798 |a XA | ||
| LOK | |0 936ln |0 1442053887 |a TK | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||
| REL | |a 1 | ||
| SUB | |a REL | ||